Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cation Transport Proteins | 3 | 2023 | 101 | 2.100 |
Why?
|
| Iron | 3 | 2023 | 305 | 1.300 |
Why?
|
| Shaker Superfamily of Potassium Channels | 3 | 2012 | 31 | 0.920 |
Why?
|
| Hepcidins | 2 | 2023 | 26 | 0.850 |
Why?
|
| Hemochromatosis | 1 | 2023 | 39 | 0.760 |
Why?
|
| Cortisone | 2 | 2012 | 10 | 0.670 |
Why?
|
| Cryoelectron Microscopy | 1 | 2020 | 241 | 0.580 |
Why?
|
| Calcium | 1 | 2023 | 1028 | 0.540 |
Why?
|
| Potassium Channels, Voltage-Gated | 3 | 2004 | 63 | 0.450 |
Why?
|
| Binding Sites | 5 | 2023 | 1143 | 0.450 |
Why?
|
| NADP | 2 | 2011 | 52 | 0.410 |
Why?
|
| Potassium Channel Blockers | 2 | 2003 | 84 | 0.390 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2011 | 39 | 0.340 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 331 | 0.320 |
Why?
|
| Hippocampus | 3 | 2004 | 801 | 0.310 |
Why?
|
| Models, Molecular | 8 | 2020 | 1056 | 0.300 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2008 | 18 | 0.290 |
Why?
|
| Aldehyde Reductase | 1 | 2008 | 18 | 0.280 |
Why?
|
| Potassium Channels | 3 | 2020 | 156 | 0.270 |
Why?
|
| Rats | 6 | 2011 | 3374 | 0.240 |
Why?
|
| Membrane Potentials | 3 | 2020 | 295 | 0.230 |
Why?
|
| Protein Binding | 3 | 2020 | 1657 | 0.230 |
Why?
|
| Ion Transport | 3 | 2020 | 48 | 0.210 |
Why?
|
| Neurons | 2 | 2004 | 2011 | 0.210 |
Why?
|
| Phenylcarbamates | 1 | 2003 | 13 | 0.200 |
Why?
|
| Carbamates | 1 | 2003 | 63 | 0.200 |
Why?
|
| Galantamine | 1 | 2003 | 9 | 0.200 |
Why?
|
| Electrophysiology | 3 | 2011 | 250 | 0.190 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2003 | 39 | 0.190 |
Why?
|
| Amyloid beta-Peptides | 1 | 2004 | 235 | 0.190 |
Why?
|
| Ion Channel Gating | 3 | 2013 | 121 | 0.180 |
Why?
|
| Pyramidal Cells | 1 | 2003 | 151 | 0.180 |
Why?
|
| Peptide Fragments | 1 | 2004 | 685 | 0.160 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2020 | 191 | 0.160 |
Why?
|
| Membrane Transport Proteins | 2 | 2012 | 179 | 0.160 |
Why?
|
| Bacterial Proteins | 3 | 2020 | 937 | 0.160 |
Why?
|
| Crystallography, X-Ray | 5 | 2013 | 364 | 0.150 |
Why?
|
| Vibrio parahaemolyticus | 3 | 2020 | 7 | 0.150 |
Why?
|
| Escherichia coli Proteins | 2 | 2020 | 311 | 0.150 |
Why?
|
| Homeostasis | 1 | 2023 | 715 | 0.140 |
Why?
|
| Oxidation-Reduction | 2 | 2011 | 435 | 0.140 |
Why?
|
| RNA, Messenger | 1 | 2004 | 2553 | 0.140 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2020 | 140 | 0.140 |
Why?
|
| Animals | 8 | 2020 | 33852 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2004 | 877 | 0.120 |
Why?
|
| Patch-Clamp Techniques | 2 | 2008 | 277 | 0.110 |
Why?
|
| Escherichia coli | 1 | 2020 | 982 | 0.100 |
Why?
|
| Yersinia | 1 | 2013 | 5 | 0.100 |
Why?
|
| Cloning, Molecular | 2 | 2012 | 778 | 0.100 |
Why?
|
| Fluticasone | 1 | 2012 | 16 | 0.090 |
Why?
|
| Rats, Wistar | 2 | 2003 | 301 | 0.090 |
Why?
|
| Androstadienes | 1 | 2012 | 50 | 0.090 |
Why?
|
| Brain | 1 | 2004 | 3188 | 0.090 |
Why?
|
| Xenopus laevis | 2 | 2012 | 121 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 411 | 0.090 |
Why?
|
| Bacillus cereus | 1 | 2011 | 10 | 0.090 |
Why?
|
| Substrate Specificity | 2 | 2011 | 286 | 0.090 |
Why?
|
| Drug Design | 1 | 2012 | 161 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 132 | 0.080 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2011 | 78 | 0.080 |
Why?
|
| Humans | 6 | 2023 | 130403 | 0.080 |
Why?
|
| DNA Primers | 1 | 2011 | 604 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2012 | 810 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2011 | 938 | 0.070 |
Why?
|
| Xenopus | 1 | 2008 | 104 | 0.070 |
Why?
|
| Binding, Competitive | 1 | 2008 | 143 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2013 | 1005 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2011 | 2397 | 0.070 |
Why?
|
| Molecular Structure | 1 | 2008 | 310 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 1454 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2011 | 3487 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2011 | 901 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2008 | 116 | 0.070 |
Why?
|
| Adenosine Diphosphate | 2 | 2020 | 50 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2008 | 582 | 0.060 |
Why?
|
| Biological Transport | 2 | 2020 | 330 | 0.060 |
Why?
|
| Oocytes | 1 | 2008 | 270 | 0.060 |
Why?
|
| Adenosine Triphosphate | 2 | 2020 | 263 | 0.060 |
Why?
|
| Kidney | 1 | 2012 | 1283 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2020 | 728 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 1723 | 0.060 |
Why?
|
| Potassium | 2 | 2020 | 269 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2008 | 770 | 0.050 |
Why?
|
| Kv1.4 Potassium Channel | 1 | 2004 | 3 | 0.050 |
Why?
|
| Delayed Rectifier Potassium Channels | 1 | 2004 | 6 | 0.050 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 2004 | 8 | 0.050 |
Why?
|
| Injections, Intraventricular | 1 | 2004 | 54 | 0.050 |
Why?
|
| Shab Potassium Channels | 1 | 2004 | 6 | 0.050 |
Why?
|
| Shal Potassium Channels | 1 | 2004 | 48 | 0.050 |
Why?
|
| Maze Learning | 1 | 2004 | 98 | 0.050 |
Why?
|
| Rivastigmine | 1 | 2003 | 15 | 0.050 |
Why?
|
| Memory Disorders | 1 | 2004 | 204 | 0.050 |
Why?
|
| Protein Structure, Quaternary | 2 | 2013 | 92 | 0.050 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2003 | 87 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2004 | 832 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 276 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 1111 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 452 | 0.040 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 548 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 714 | 0.040 |
Why?
|
| X-Ray Diffraction | 1 | 2020 | 100 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1610 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 137 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2020 | 330 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2020 | 521 | 0.030 |
Why?
|
| Rotation | 1 | 2013 | 33 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 4654 | 0.030 |
Why?
|
| Male | 3 | 2004 | 64486 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2013 | 80 | 0.020 |
Why?
|
| Osmosis | 1 | 2012 | 17 | 0.020 |
Why?
|
| Sodium | 1 | 2013 | 280 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2012 | 96 | 0.020 |
Why?
|
| Metabolism | 1 | 2012 | 45 | 0.020 |
Why?
|
| Protein Folding | 1 | 2013 | 215 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2013 | 450 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 125 | 0.020 |
Why?
|
| Urea | 1 | 2012 | 218 | 0.020 |
Why?
|
| Liposomes | 1 | 2012 | 196 | 0.020 |
Why?
|
| Bile Acids and Salts | 1 | 2013 | 259 | 0.020 |
Why?
|
| Crystallization | 1 | 2011 | 83 | 0.020 |
Why?
|
| Cattle | 1 | 2012 | 501 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2011 | 51 | 0.020 |
Why?
|
| Ligands | 1 | 2012 | 486 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 1569 | 0.020 |
Why?
|
| Proteins | 1 | 2012 | 1006 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2923 | 0.020 |
Why?
|
| Female | 1 | 2008 | 70343 | 0.010 |
Why?
|